KRAS, which functions as a signal transducer between cell membrane-based growth factor signaling and the MAPK pathways, is the most frequently mutated oncogene (~ 90% of pancreatic cancer ) 5, 6. Here, KRAS is linked to familial pancreatic carcinoma.